DADaniel Rodrigo Cavalcante de Araújo

Daniel Rodrigo Cavalcante de Araújo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daniel Rodrigo Cavalcante de Araújo has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Potentialities of Cashew Nut (Anacardium occidentale) By-Product for Pharmaceutical Applications: Extraction and Purification Technologies, Safety, and Anti-inflammatory and Anti-arthritis Activities

    by Ariane Teixeira dos Santos, Gerlane Coelho Bernardo Guerra, José Ivan Marques, Manoela Torres-Rêgo, Jovelina Samara Ferreira Alves, Roseane Carvalho Vasconcelos, Daline Fernandes de Souza Araújo, Lucas Silva Abreu, Thaís Gomes de Carvalho, Daniel Rodrigo Cavalcante de Araújo, et al.


  • Open Access

    Bioguided Purification of Active Compounds from Leaves of Anadenanthera colubrina var. cebil (Griseb.) Altschul

    by Daniel Rodrigo Cavalcante de Araújo, Túlio Diego da Silva, Wolfgang Harand, Claudia Sampaio de Andrade Lima, João Paulo Ferreira Neto, Bárbara de Azevedo Ramos, Tamiris Alves Rocha, Harley da Silva Alves, Rayane Sobrinho de Sousa, Ana Paula de Oliveira, et al.

    Anadenanthera colubrina var cebil (Griseb.) Altschul is a medicinal plant found throughout the Brazilian semi-arid area. This work performed a bioguided purification of active substances present in ethyl acetate extract from A. colubrina leaves. The anti-Staphylococcus aureus and antioxidant actions were used as markers of bioactivity. The extract was subjected to flash chromatography resulting in five fractions (F1, F2, F3, F4, and F5). The fractions F2 and F4 presented the highest antimicrobial action, with a dose able to inhibit 50% of bacteria growth (IN50) of 19.53 μg/mL for S. aureus UFPEDA 02; whereas F4 showed higher inhibitory action towards DPPH radical (2,2-diphenyl-1-picryl-hydrazyl-hydrate) [dose able to inhibit 50% of the radical (IC50) = 133 ± 9 μg/mL]. F2 and F4 were then subjected to preparative high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR), resulting in the identification of p-hydroxybenzoic acid and hyperoside as the major compounds in F2 and F4, respectively. Hyperoside and p-hydroxybenzoic acid presented IN50 values of 250 μg/mL and 500 μg/mL against S. aureus UFPEDA 02, respectively. However, the hyperoside had an IN50 of 62.5 μg/mL against S. aureus UFPEDA 705, a clinical isolate with multidrug resistant phenotype. Among the purified compounds, the proanthocyanidins obtained from F2 exhibited the higher antioxidant potentials. Taken together, these results highlight the potential of A. colubrina leaves as an alternative source of biomolecules of interest for the pharmaceutical, food, and cosmetic industries.